Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Raw Materials (2016 - 2019)

Tandem Diabetes Care's Raw Materials history spans 6 years, with the latest figure at $9.6 million for Q1 2019.

  • For Q1 2019, Raw Materials fell 7.79% year-over-year to $9.6 million; the TTM value through Mar 2019 reached $9.6 million, down 7.79%, while the annual FY2018 figure was $6.6 million, 35.88% down from the prior year.
  • Raw Materials reached $9.6 million in Q1 2019 per TNDM's latest filing, up from $6.6 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $12.1 million in Q2 2016 to a low of $6.6 million in Q4 2018.
  • Average Raw Materials over 5 years is $9.9 million, with a median of $10.0 million recorded in 2016.
  • Peak YoY movement for Raw Materials: surged 49.7% in 2015, then crashed 35.88% in 2018.
  • A 5-year view of Raw Materials shows it stood at $10.6 million in 2015, then decreased by 11.61% to $9.4 million in 2016, then grew by 10.17% to $10.3 million in 2017, then plummeted by 35.88% to $6.6 million in 2018, then skyrocketed by 44.74% to $9.6 million in 2019.
  • Per Business Quant, the three most recent readings for TNDM's Raw Materials are $9.6 million (Q1 2019), $6.6 million (Q4 2018), and $8.6 million (Q3 2018).